Provided by Tiger Trade Technology Pte. Ltd.

Zevra Therapeutics

11.65
-0.2200-1.85%
Post-market: 11.870.2200+1.89%18:06 EDT
Volume:784.46K
Turnover:9.20M
Market Cap:688.69M
PE:12.13
High:12.01
Open:11.98
Low:11.45
Close:11.87
52wk High:15.04
52wk Low:7.16
Shares:59.11M
Float Shares:53.86M
Volume Ratio:0.89
T/O Rate:1.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9602
EPS(LYR):1.35
ROE:34.80%
ROA:8.74%
PB:3.16
PE(LYR):8.63

Loading ...

Ligand Pharma to acquire fellow biotech royalty rights buyer XOMA for $739 million

Reuters
·
Apr 27

Zevra Therapeutics schedules first-quarter results conference call

Reuters
·
Apr 22

BTIG Sticks to Their Buy Rating for Zevra Therapeutics (ZVRA)

TIPRANKS
·
Apr 06

Zevra Therapeutics announces annual shareholder meeting notice

Reuters
·
Apr 06

Zevra Therapeutics grants CFO Justin Renz 300,000-share option at USD 9.55 exercise price

Reuters
·
Mar 21

Press Release: Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

Dow Jones
·
Mar 21

Zevra Therapeutics CFO Justin A. Renz Files Initial Beneficial Ownership Statement

Reuters
·
Mar 20

Zevra Therapeutics sells SDX portfolio to Commave Therapeutics for USD 50 million

Reuters
·
Mar 16

BTIG Initiates Zevra Therapeutics at Buy With $23 Price Target

MT Newswires Live
·
Mar 16

Zevra Therapeutics Initiated at Buy by BTIG

Dow Jones
·
Mar 16

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Verrica Pharmaceuticals (VRCA) and Beyond Air (XAIR)

TIPRANKS
·
Mar 12

Zevra Therapeutics Faces Partnership Hurdles That Could Delay Drug Development and Pressure Financing

TIPRANKS
·
Mar 11

Why Is Zevra Therapeutics Stock Trading Higher Today?

Benzinga_recent_news
·
Mar 11

Nio, Zevra Therapeutics, Vertex Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

Benzinga_recent_news
·
Mar 10

Zevra Therapeutics (ZVRA) Gets a Buy from Roth MKM

TIPRANKS
·
Mar 10

Top Premarket Gainers

MT Newswires Live
·
Mar 10

Zevra Therapeutics price target raised to $23 from $22 at Guggenheim

TIPRANKS
·
Mar 10

Zevra Therapeutics: Strong NPC Enrollment Momentum and Undervalued Rare-Disease Pipeline Support Buy Rating and $26 Target

TIPRANKS
·
Mar 10

Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), Jazz Pharmaceuticals (JAZZ) and Talkspace (TALK)

TIPRANKS
·
Mar 10

Why Zevra Therapeutics Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket

Benzinga_recent_news
·
Mar 10